Clinical trial
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
NCT01437878 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
- Lead sponsor
- Actelion
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2012
- Completion date
- November 30, 2012
- Enrollment
- 2 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease, pulmonary hypertension